Non-Small Cell Lung Cancers (NSCLCs) Oncolysis Using Coxsackievirus B5 and Synergistic DNA-Damage Response Inhibitors

Coxsackievirus B5/Faulkner was screened for its potential oncolytic effect against NSCLCs through inducing apoptosis and autophagy.